These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2666094)

  • 41. [Acute abdomen during cytostatic therapy of acute leukemias].
    Griefahn B; Reddemann H
    Kinderarztl Prax; 1977 Nov; 45(11):488-93. PubMed ID: 604627
    [No Abstract]   [Full Text] [Related]  

  • 42. In vitro assessment of drug sensitivity in acute nonlymphocytic leukemia.
    Preisler HD; Raza A
    Recent Results Cancer Res; 1984; 94():102-15. PubMed ID: 6593774
    [No Abstract]   [Full Text] [Related]  

  • 43. Drug screening and biological systems.
    Taetle R; Abramson I
    J Natl Cancer Inst; 1988 Jul; 80(10):720-1. PubMed ID: 3385779
    [No Abstract]   [Full Text] [Related]  

  • 44. Bench-to-bedside research and the human tumor stem-cell assay--bridging the credibility gap.
    Browman GP; Levine MN; Roberts RS
    J Clin Oncol; 1986 Dec; 4(12):1730-1. PubMed ID: 3783200
    [No Abstract]   [Full Text] [Related]  

  • 45. [An in vitro antiblastic drug sensitivity test in bladder carcinoma. Preliminary research].
    Tizzani A; Cocimano V; Frea B; Piana P; Casetta G; Viano I; Silvestro L; Genazzani A
    Minerva Urol Nefrol; 1986; 38(1):1-4. PubMed ID: 3738669
    [No Abstract]   [Full Text] [Related]  

  • 46. [Cytostatic drugs. Part 5 (conclusion): Other cytostatically active drugs].
    Sauer H
    Fortschr Med; 1991 Oct; 109(30):619-20. PubMed ID: 1761266
    [No Abstract]   [Full Text] [Related]  

  • 47. Semi-micro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in-vitro chemosensitivity of haematological malignancies.
    Bird MC; Bosanquet AG; Forskitt S; Gilby ED
    Leuk Res; 1986; 10(4):445-9. PubMed ID: 2421109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting chemosensitivity of tumors.
    Mattern J; Wayss K; Volm M
    Breast Cancer Res Treat; 1986; 8(2):157-9. PubMed ID: 3814835
    [No Abstract]   [Full Text] [Related]  

  • 49. Potential of colony-forming cell assays in the evaluation of ovarian cancer.
    Aapro MS; Vermorken JB
    Eur J Cancer Clin Oncol; 1988 Mar; 24(3):357-8. PubMed ID: 3383939
    [No Abstract]   [Full Text] [Related]  

  • 50. [Symposium on treatment of cancer. Supplement 2. Differential sensitivities of long-term cultured cell lines derived from human haematopoietic malignancies to various anti-cancer drugs].
    Morikawa K; Note S
    Nihon Naika Gakkai Zasshi; 1984 Nov; 73(11):1625-7. PubMed ID: 6520521
    [No Abstract]   [Full Text] [Related]  

  • 51. Adhesive tumor cell culture system.
    J Clin Oncol; 1988 Jan; 6(1):178-9. PubMed ID: 3335889
    [No Abstract]   [Full Text] [Related]  

  • 52. [Recent progress in the treatment of hematological malignancies. I. Anticancer agents].
    Wakisaka G; Nakamura T
    Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):753-8. PubMed ID: 2794656
    [No Abstract]   [Full Text] [Related]  

  • 53. [Progress in hematology. Therapy of acute leukemias].
    Kopeć M; Plachecka-Gutowska M
    Pol Arch Med Wewn; 1966; 36(6):883-7. PubMed ID: 5330093
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cytostatic treatment of cancer--realistic expectations?].
    Kvinnsland S
    Tidsskr Nor Laegeforen; 1992 Jan; 112(3):318-9. PubMed ID: 1553662
    [No Abstract]   [Full Text] [Related]  

  • 55. [The planning of therapeutic trials in leukemias].
    Lange J; Schumacher K
    Methods Inf Med; 1962 Jul; 1(3):95-9. PubMed ID: 21735877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cytostatic therapy of leukoses].
    GRUNKE W
    Z Gesamte Inn Med; 1958 Oct; 13(19):738-44. PubMed ID: 13616462
    [No Abstract]   [Full Text] [Related]  

  • 57. [Cytostatic agents].
    ROUSSO C
    Rev Prat; 1959 Jul; 9(19):2107-9 passim. PubMed ID: 13675652
    [No Abstract]   [Full Text] [Related]  

  • 58. [The behavior of basic metabolism in leukemias].
    CHIANCA L; AMATI G
    Riforma Med; 1948 Aug; 62(29-30):413-8. PubMed ID: 18883631
    [No Abstract]   [Full Text] [Related]  

  • 59. [Cytostatic-sensitive and cytostatic-resistant leukemias].
    Vilpo JA
    Duodecim; 1989; 105(11):1117-22. PubMed ID: 2666094
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pretherapeutic studies of tumors in vivo. Cytokinetics and cytostatic tumor changes in diffusion chambers].
    Ohl S
    Fortschr Med; 1985 Mar; 103(11):298-300. PubMed ID: 3988201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.